Sign In
Buy STVN
$18.53
-0.260 (-1.38%)
At Close: Jun 03, 2026
Stevanato Group (STVN) Q1 Earnings and Revenues Top Estimates
08:50am, Thursday, 08'th May 2025
Stevanato Group (STVN) came out with quarterly earnings of $0.11 per share, beating the Zacks Consensus Estimate of $0.10 per share. This compares to earnings of $0.09 per share a year ago.
Stevanato Group Reports Revenue of €256.6 Million for the First Quarter of 2025
06:37am, Thursday, 08'th May 2025
PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology,
SDZNY vs. STVN: Which Stock Should Value Investors Buy Now?
12:46pm, Tuesday, 06'th May 2025
Investors interested in stocks from the Medical - Drugs sector have probably already heard of Sandoz Group AG Sponsored ADR (SDZNY) and Stevanato Group (STVN). But which of these two stocks presents i
Stevanato S p A : PWC Stevanato Group SpA Report on the Audit of the Consolidated Financial Statements
07:02am, Monday, 28'th Apr 2025
Independent auditor's report in accordance with article 14 of Legislative Decree No. 39 of 27 January 2010 To the shareholders of Stevanato Group SpA aAdsList.push('Article'); aAdsListSize.push([300,
Stevanato S p A : PWC Stevanato Group SpA Report on the Audit of the Financial Statements
07:02am, Monday, 28'th Apr 2025
Independent auditor's report in accordance with article 14 of Legislative Decree No. 39 of 27 January 2010 To the shareholders of Stevanato Group SpA aAdsList.push('Article'); aAdsListSize.push([300,
Stevanato S p A : Holding Srl Slate of Candidate Directors
07:02am, Monday, 28'th Apr 2025
STEVANATO HOLDING S.R.L. FTE 'ANATO GROLW S.P.A. aAdsList.push('Article'); aAdsListSize.push([300, 250]); aAdsListCA.push(null); 4"In MOLINELLA. 1.7, 35017 PiOMBINO DESE - PADOVA ITALY Pioinbino Dese.
Stevanato S p A : Group SpA ESG Report 2024
07:02am, Monday, 28'th Apr 2025
Sustainability Report 2024 Stevanato Group Sustainability Economic Value Innovation Human Capital Supply Chain Environment Local Communities aAdsList.push('Article'); aAdsListSize.push([300, 250]); aA
Stevanato Group to Report First Quarter 2025 Financial Results on May 8, 2025
05:15pm, Thursday, 24'th Apr 2025
PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology,
Stevanato Group to Participate in the KeyBanc Capital Markets Virtual Healthcare Forum
04:30pm, Tuesday, 11'th Mar 2025
PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology,
Stevanato: Ramping Syringe Demand, Buy Confirmed
02:37pm, Sunday, 09'th Mar 2025
Stevanato's 2024 revenue reached €1.1 billion, surpassing analyst expectations. This growth was driven by Biopharmaceutical and Diagnostic Solutions, despite a challenging year with inventory issues
Stevanato Group S.p.A. (STVN) Q4 2024 Earnings Call Transcript
12:33pm, Thursday, 06'th Mar 2025
Stevanato Group S.p.A. (NYSE:STVN ) Q4 2024 Earnings Conference Call March 6, 2025 8:30 AM ET Company Participants Lisa Miles - SVP, IR Franco Stevanato - Chairman and CEO Marco Dal Lago - CFO Confere
Stevanato Group (STVN) Meets Q4 Earnings Estimates
08:45am, Thursday, 06'th Mar 2025
Stevanato Group (STVN) came out with quarterly earnings of $0.20 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.19 per share a year ago.
Stevanato Group Reports Record Revenue of €1,104 Million for Fiscal Year 2024
06:31am, Thursday, 06'th Mar 2025
PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology,
Stevanato Group to Report Fourth Quarter and Fiscal Year 2024 Financial Results on March 6, 2025
04:02pm, Monday, 24'th Feb 2025
PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology
USNA or STVN: Which Is the Better Value Stock Right Now?
12:46pm, Friday, 14'th Feb 2025
Investors interested in Medical - Drugs stocks are likely familiar with USANA Health Sciences (USNA) and Stevanato Group (STVN). But which of these two stocks presents investors with the better value
